CVE:HIV HIVE Blockchain Technologies (HIV) Stock Price, News & Analysis Add Compare Share Share Stock Analysis Stock AnalysisBuy This Stock About HIVE Blockchain Technologies Stock (CVE:HIV) 30 days 90 days 365 days Advanced Chart Get HIV alerts:Sign Up Key Stats Today's Range N/A50-Day Range N/A52-Week Range N/AVolumeN/AAverage VolumeN/AMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingStrong Buy Company OverviewRead More… Receive HIV Stock News and Ratings via Email Sign-up to receive the latest news and ratings for HIVE Blockchain Technologies and its competitors with MarketBeat's FREE daily newsletter. Email Address HIV Stock News HeadlinesThe Zacks Analyst Blog Highlights NVIDIA, Visa, HIVE Blockchain and AccentureMay 2, 2025 | theglobeandmail.comBitcoin miner HIVE Digital completes the first 100 MW facility in ParaguayApril 23, 2025 | thestreet.comBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the quiet buildup behind the scenes. Now, in just days, the floodgates are set to open. The greatest investor of all time is about to validate what Garrett Goggin has been saying for months: Gold is entering a once-in-a-generation mania. Front-running Buffett has never been more urgent — and four tiny miners could be your ticket to 100X gains.May 25, 2025 | Golden Portfolio (Ad)Hive Digital (HIVE) Expands AI & Crypto Mining With $220M BTC HoldingsMarch 15, 2025 | msn.comWhite House crypto summit snubs Bitcoin miners, HIVE Digital chairman calls it a 'mistake'March 15, 2025 | msn.comRosenblatt Initiates Coverage of HIVE Digital Technologies (HIVE) with Buy RecommendationMarch 7, 2025 | msn.comHIVE Digital Technologies: Stocks Undervalued by Analyst Consensus on TSX-V (HIVE)February 15, 2025 | theglobeandmail.comHive Digital price target raised to $10 from $8 at H.C. WainwrightFebruary 14, 2025 | markets.businessinsider.comSee More Headlines HIV Stock Analysis - Frequently Asked Questions How were HIVE Blockchain Technologies' earnings last quarter? HIVE Blockchain Technologies Ltd. (CVE:HIV) issued its quarterly earnings results on Tuesday, November, 12th. The company reported ($0.08) earnings per share for the quarter, topping the consensus estimate of ($0.12) by $0.04. How do I buy shares of HIVE Blockchain Technologies? Shares of HIV stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers. What other stocks do shareholders of HIVE Blockchain Technologies own? Based on aggregate information from My MarketBeat watchlists, some other companies that HIVE Blockchain Technologies investors own include ProShares Bitcoin ETF (BITO), Meta Platforms (META), Broadcom (AVGO), MARA (MARA), NVIDIA (NVDA), Riot Platforms (RIOT) and Shopify (SHOP). Company Calendar Last Earnings11/12/2024Today5/25/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeCVE SectorBusiness Services Industry Services – Management, Public Relations, Consulting Sub-IndustryBusiness Services Current SymbolCVE:HIV CIKN/A WebN/A Phone(716) 272-8400FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A Beginner's Guide To Retirement StocksEnter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio. Get This Free Report This page (CVE:HIV) was last updated on 5/25/2025 by MarketBeat.com Staff From Our PartnersGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredIs President Trump Lying To You With This?President Trump’s economic transition isn’t without hardship. But what if there were a smart, tax-free way to ...Colonial Metals | SponsoredA grave, grave error.I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredTrump’s Bitcoin Reserve is No Accident…Bitcoin's supply is being drained at unprecedented rates, but while most investors focus solely on Bitcoin, th...Crypto 101 Media | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredMassive new energy source found in UtahNEW THIS WEEK: Huge Energy Discovery In Utah The Department of Energy say it could power America for millio...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding HIVE Blockchain Technologies Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share HIVE Blockchain Technologies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy HIV Stock Free HIV Stock Alerts